...
首页> 外文期刊>Vaccine >Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles
【24h】

Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles

机译:通过吸附到阳离子PLG微粒上来增强结核病DNA疫苗的保护功效

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Immunization with plasmid DNA vectors represents a promising new approach to vaccination. It has been shown to elicit humoral and cellular immunity and protection in various infection models. Here, we assessed the immunogenicity and protective efficacy of a DNA vaccine vector encoding the antigen 85A (Ag85A) of Mycobacterium tuberculosis. Since intramuscular (i.m.) immunization with naked DNA requires considerable amounts of DNA in order to be effective, we evaluated a strategy to reduce the amount of DNA needed. To this end, we used Ag85A DNA adsorbed onto cationic poly(DL-lactide-co-glycolide) (PLG) microparticles and observed similar levels of protection against aerosol challenge in mice using doses of PLG-DNA two orders of magnitude lower than with naked DNA itself.
机译:用质粒DNA载体免疫代表了一种有希望的新疫苗接种方法。它已经显示出在各种感染模型中引起体液和细胞免疫以及保护。在这里,我们评估了编码结核分枝杆菌抗原85A(Ag85A)的DNA疫苗载体的免疫原性和保护功效。由于使用裸露的DNA进行肌内(i.m.)免疫需要大量的DNA才能有效,因此我们评估了减少所需DNA数量的策略。为此,我们使用吸附在阳离子聚(DL-丙交酯-共-乙交酯)(PLG)微粒上的Ag85A DNA并观察到小鼠使用类似剂量的PLG-DNA剂量要比裸剂量低两个数量级,从而对小鼠的气溶胶攻击具有相似的保护水平DNA本身。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号